XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Revenues:        
Total revenues $ 12,336,423 $ 10,459,856 $ 22,369,064 $ 21,218,047
Expenses:        
Cost of product revenues 8,685,328 5,697,063 17,226,902 12,321,164
Research and development 1,839,663 3,132,259 3,940,416 5,444,476
Selling, general and administration 7,267,868 6,466,120 14,499,733 11,114,250
Litigation damages 24,800,000
Total expenses 17,792,859 15,295,442 60,467,051 28,879,890
Loss from operations (5,456,436) (4,835,586) (38,097,987) (7,661,843)
Other (expense) income        
Interest income 226,677 222,700 399,517 324,465
Other income 18,867 35,765 18,824 72,795
Loss on impairment of investments (734,286) (3,327,347) (734,286) (3,327,347)
Foreign currency transaction gains (losses) 23,180 (236,911) (56,281) (139,004)
Total other expense, net (465,562) (3,305,793) (372,226) (3,069,091)
Loss before provision for income taxes (5,921,998) (8,141,379) (38,470,213) (10,730,934)
Tax provision (39,000) (78,000)
Net loss $ (5,921,998) $ (8,180,379) $ (38,470,213) $ (10,808,934)
Net loss per share        
Basic $ (0.05) $ (0.07) $ (0.32) $ (0.10)
Diluted $ (0.05) $ (0.07) $ (0.32) $ (0.10)
Weighted average number of common shares outstanding        
Basic 121,400,739 109,911,244 120,757,868 107,473,813
Diluted 121,400,739 109,911,244 120,757,868 107,473,813
Net Product Revenues [Member]        
Revenues:        
Total revenues $ 11,054,030 $ 6,011,393 $ 20,079,396 $ 13,666,109
Research and Development Revenues [Member]        
Revenues:        
Total revenues 1,170,329 3,884,225 2,070,294 6,780,676
Other Revenues [Member]        
Revenues:        
Total revenues $ 112,064 $ 564,238 $ 219,374 $ 771,262